NasdaqCM - Nasdaq Real Time Price USD

Pieris Pharmaceuticals, Inc. (PIRS)

11.72 +0.12 (+1.03%)
At close: April 26 at 4:00 PM EDT
11.38 -0.34 (-2.90%)
After hours: April 26 at 7:50 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
47,357.00
25,902.00
31,418.00
29,323.00
Operating Expense
62,235.00
61,203.00
79,564.00
63,244.00
Operating Income
-14,878.00
-35,301.00
-48,146.00
-33,921.00
Net Non Operating Interest Income Expense
1,747.00
721.00
4.00
511.00
Other Income Expense
-14,930.00
1,303.00
2,404.00
-3,656.00
Pretax Income
-28,061.00
-33,277.00
-45,738.00
-37,066.00
Tax Provision
--
--
--
164.00
Net Income Common Stockholders
-28,061.00
-33,277.00
-45,738.00
-37,230.00
Diluted NI Available to Com Stockholders
-28,061.00
-33,277.00
-45,738.00
-37,230.00
Basic EPS
-0.34
-0.45
-0.71
-0.68
Diluted EPS
-0.34
-0.45
-0.71
-0.68
Basic Average Shares
83,931.75
74,172.00
64,547.00
54,481.00
Diluted Average Shares
83,931.75
74,172.00
64,547.00
54,481.00
Total Operating Income as Reported
-36,774.00
-43,474.00
-51,831.00
-33,921.00
Total Expenses
62,235.00
61,203.00
79,564.00
63,244.00
Net Income from Continuing & Discontinued Operation
-28,061.00
-33,277.00
-45,738.00
-37,230.00
Normalized Income
-13,168.00
-33,277.00
-45,738.00
-37,230.00
Interest Income
1,747.00
721.00
4.00
511.00
Net Interest Income
1,747.00
721.00
4.00
511.00
EBIT
-14,878.00
-35,301.00
-48,146.00
-33,921.00
EBITDA
-12,289.00
-32,521.00
-45,778.00
-31,794.00
Reconciled Depreciation
2,589.00
2,780.00
2,368.00
2,127.00
Net Income from Continuing Operation Net Minority Interest
-28,061.00
-33,277.00
-45,738.00
-37,230.00
Total Unusual Items Excluding Goodwill
-14,893.00
--
--
--
Total Unusual Items
-14,893.00
--
--
--
Normalized EBITDA
2,604.00
-32,521.00
-45,778.00
-31,794.00
Tax Rate for Calcs
--
--
--
0.00
12/31/2020 - 1/2/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BPTS Biophytis S.A.
8.22
0.00%
 
WINT Windtree Therapeutics, Inc.
5.23
+2.55%
 
LPTX Leap Therapeutics, Inc.
3.2500
+2.52%
 
ATXI Avenue Therapeutics, Inc.
6.20
-29.35%
 
GRTX Galera Therapeutics, Inc.
0.1861
-10.31%
 
AFMD Affimed N.V.
5.03
+3.07%
 
LVTX LAVA Therapeutics N.V.
2.7300
+3.41%
 
CDTX Cidara Therapeutics, Inc.
12.63
-2.85%
 
CTMX CytomX Therapeutics, Inc.
1.5900
-0.62%
 
PHIO Phio Pharmaceuticals Corp.
0.6820
+1.34%